Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
21 Mars 2025 - 9:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
| | |
| ¨ | Preliminary Proxy Statement |
| | |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| | |
| ¨ | Definitive Proxy Statement |
| | |
| x | Definitive Additional Materials |
| | |
| ¨ | Soliciting Material under §240.14a-12 |
West Pharmaceutical Services, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| | |
| ¨ | Fee paid previously with preliminary materials. |
| | |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 |

| Your Vote Counts!
WEST PHARMACEUTICAL SERVICES, INC.
You invested in WEST PHARMACEUTICAL SERVICES, INC. and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the
availability of proxy materials for the shareholder meeting to be held on May 6, 2025.
Vote Virtually at the Meeting*
May 6, 2025
9:30 AM EDT
Virtually at:
www.virtualshareholdermeeting.com/WST2025
*Please check the meeting materials for any special requirements for meeting attendance.
Smartphone users
Point your camera here and
vote without entering a
control number
For complete information and to vote, visit www.ProxyVote.com
Control #
V62352-P26361
Get informed before you vote
View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by
requesting prior to April 22, 2025. If you would like to request a copy of the material(s) for this and/or future shareholder meetings,
you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an
email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a
paper or email copy.
WEST PHARMACEUTICAL SERVICES, INC.
C/O BROADRIDGE CORPORATE ISSUER SOLUTIONS
P.O. BOX 1342
BRENTWOOD, NY 11717
2025 Annual Meeting
Vote by May 5, 2025 11:59 PM EDT. For shares held in a
Plan, vote by May 1, 2025 11:59 PM EDT. |

| THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming shareholder meeting. Please follow the instructions on
the reverse side to vote these important matters.
Vote at www.ProxyVote.com
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.
Voting Items
Board
Recommends
V62353-P26361
1. Election of Directors;
Nominees:
1a. Mark A. Buthman For
1b. William F. Feehery For
1c. Robert F. Friel For
1d. Eric M. Green For
1e. Janet B. Haugen For
1f. Thomas W. Hofmann For
1g. Molly E. Joseph For
1h. Deborah L. V. Keller For
1i. Myla P. Lai-Goldman For
1j. Stephen H. Lockhart For
1k. Douglas A. Michels For
1l. Paolo Pucci For
2. Advisory vote to approve named executive officer compensation; For
3. Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a
Special Meeting; For
4. Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and For
5. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm
for 2025. For
NOTE: Such other business as may properly come before the meeting or any adjournment thereof. |
West Pharmaceutical Serv... (NYSE:WST)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025
West Pharmaceutical Serv... (NYSE:WST)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025